MicroRNA-150 Protects Against Pressure Overload-Induced Cardiac Hypertrophy

Journal of Cellular Biochemistry

Volumn 116, Issue 10, 2015, Pages 2166-2176

  Liu, Wanli ^a   Liu, Yu ^a   Zhang, Yan ^a   Zhu, Xueyong ^a   Zhang, Rui ^a   Guan, Lihua ^a   Tang, Qizhu ^a   Jiang, Hong ^a   Huang, Congxin ^a   Huang, He ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

HYPERTROPHY; MICRORNA; SIGNAL TRANSDUCTION; SRF

Indexed keywords

ANTAGOMIR; MICRORNA; MICRORNA 150; SERUM RESPONSE FACTOR; UNCLASSIFIED DRUG; MIRN150 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; GAIN OF FUNCTION MUTATION; GENE OVEREXPRESSION; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; LOSS OF FUNCTION MUTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ARTERIAL PRESSURE; BIOSYNTHESIS; CARDIOMEGALY; DISEASE MODEL; FIBROSIS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; PATHOLOGY; TRANSGENIC MOUSE;

MURINAE; MUS MUSCULUS;

ANIMALS; ARTERIAL PRESSURE; CARDIOMEGALY; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBROSIS; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, TRANSGENIC; MICRORNAS; SERUM RESPONSE FACTOR;

EID: 84939185722     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25057     Document Type: Article

References (32)

1. + overload and cell death. J Clin Invest 122: 1222-1232.
2. Balza RO Jr, Misra RP,. 2006. Role of the serum response factor in regulating contractile apparatus gene expression and sarcomeric integrity in cardiomyocytes. J Biol Chem 281: 6498-6510.
3. Bian Z, Dai J, Hiroyasu N, Guan H, Yuan Y, Gan L, Zhou H, Zong J, Zhang Y, Li F, Yan L, Shen D, Li H, Tang Q,. 2014. Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis. J Cell Biochem 115: 349-358.
4. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G,. 2007. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618.
5. Da Costa Martins PA, De Windt LJ,. 2012. MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res 93: 563-572.
6. Fulci V, Chiaretti S, Goldoni M, Azzalin G, Carucci N, Tavolaro S, Castellano L, Magrelli A, Citarella F, Messina M, Maggio R, Peragine N, Santangelo S, Mauro FR, Landgraf P, Tuschl T, Weir DB, Chien M, Russo JJ, Ju J, Sheridan R, Sander C, Zavolan M, Guarini A, Foà R, Macino G,. 2007. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109: 4944-4951.
7. Jing Q, Huang S, Guth S, Zarubin T, Motoyama A, Chen J, Di Padova F, Lin SC, Gram H, Han J,. 2005. Involvement of microRNA in AU-rich element-mediated mRNA instability. Cell 120: 623-634.
8. Kuwahara K, Teg Pipes GC, McAnally J, Richardson JA, Hill JA, Bassel-Duby R, Olson EN,. 2007. Modulation of adverse cardiac remodeling by STARS, a mediator of MEF2 signaling and SRF activity. J Clin Invest 117: 1324-1334.
9. Li H, He C, Feng J, Zhang Y, Tang Q, Bian Z, Bai X, Zhou H, Jiang H, Heximer SP, Qin M, Huang H, Liu PP, Huang C,. 2010. Regulator of G protein signaling 5 protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. Proc Natl Acad Sci USA 107: 13818-13823.
10. Lin Z, Murtaza I, Wang K, Jiao J, Gao J, Li PF,. 2009. MiR-23a functions downstream of NFATc3 to regulate cardiac hypertrophy. Proc Natl Acad Sci USA 106: 12103-12108.
11. Liu Y, Huang H, Zhang Y, Zhu XY, Zhang R, Guan LH, Tang Q, Jiang H, Huang C,. 2014. Regulator of G protein signaling 3 protects against cardiac hypertrophy in mice. J Cell Biochem 115: 977-986.
12. Lorell BH, Carabello BA,. 2000. Left ventricular hypertrophy: Pathogenesis, detection, and prognosis. Circulation 102: 470-479.
13. McDonald OG, Wamhoff BR, Hoofnagle MH, Owens GK,. 2006. Control of SRF binding to CArG box chromatin regulates smooth muscle gene expression in vivo. J Clin Invest 116: 36-48.
14. Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E,. 2011. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124: 1537-1547.
15. Nelson TJ, Balza R Jr, Xiao Q, Misra RP,. 2005. SRF-dependent gene expression in isolated cardiomyocytes: Regulation of genes involved in cardiac hypertrophy. J Mol Cell Cardiol 39: 479-489.
16. Parlakian A, Charvet C, Escoubet B, Mericskay M, Molkentin JD, Gary-Bobo G, De Windt LJ, Ludosky MA, Paulin D, Daegelen D, Tuil D, Li Z,. 2005. Temporally controlled onset of dilated cardiomyopathy through disruption of the SRF gene in adult heart. Circulation 112: 2930-2939.
17. Parlakian A, Tuil D, Hamard G, Tavernier G, Hentzen D, Concordet JP, Paulin D, Li Z, Daegelen D,. 2004. Targeted inactivation of serum response factor in the developing heart results in myocardial defects and embryonic lethality. Mol Cell Biol 24: 5281-5289.
18. Ruilope LM, Schmieder RE,. 2008. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 21: 500-508.
19. Sandbo N, Kregel S, Taurin S, Bhorade S, Dulin NO,. 2009. Critical role of serum response factor in pulmonary myofibroblast differentiation induced by TGF-beta. Am J Respir Cell Mol Biol 41: 332-338.
20. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M,. 2007. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424.
21. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, Dimaio JM, Sadek H, Kuwahara K, Olson EN,. 2010. Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction. Circ Res 107: 294-304.
22. van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN,. 2006. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103: 18255-18260.
23. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, Fernandez MH, Tulbure D, Bueso-Ramos CE, Negrini M, Calin GA,. 2009. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 4: e7405.
24. Wang X, Zhang X, Ren XP, Chen J, Liu H, Yang J, Medvedovic M, Hu Z, Fan GC,. 2010. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation 122: 1308-1318.
25. Watanabe A, Tagawa H, Yamashita J, Teshima K, Nara M, Iwamoto K, Kume M, Kameoka Y, Takahashi N, Nakagawa T, Shimizu N, Sawada K,. 2011. The role of microRNA-150 as a tumor suppressor in malignant lymphoma. Leukemia 25: 1324-1334.
26. Wu L, Fan J, Belasco JG,. 2006. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA 103: 4034-4039.
27. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J, Rajewsky N, Bender TP, Rajewsky K,. 2007. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 131: 146-159.
28. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z,. 2007. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med 13: 486-491.
29. Zhang X, Azhar G, Chai J, Sheridan P, Nagano K, Brown T, Yang J, Khrapko K, Borras AM, Lawitts J, Misra RP, Wei JY,. 2001. Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor. Am J Physiol Heart Circ Physiol 280: H1782-H1792.
30. Zhang X, Azhar G, Helms SA, Wei JY,. 2011. Regulation of cardiac microRNAs by serum response factor. J Biomed Sci 18: 15.
31. Zhou L, Qi X, Potashkin JA, Abdul-Karim FW, Gorodeski GI,. 2008. MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2×7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript. J Biol Chem 283: 28274-28286.
32. Zong J, Zhang DP, Zhou H, Bian ZY, Deng W, Dai J, Yuan Y, Gan HW, Guo HP, Tang QZ,. 2013. Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling. J Cell Biochem 114: 1058-1065.